Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Income | $58.1M | $79.4M | $105.0M | $122.8M | $132.9M | $126.3M | $143.5M | $153.7M | $156.4M | $133.4M | $168.4M | $184.5M | $178.7M | $113.0M | $243.6M | $257.4M | $389.7M | $343.0M | $343.5M | $340.6M |
Discover the top 20 best undervalued stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Feb 2025.
As of today, Chemed Corporation's last 12-month Operating Income is $364.0M, based on the financial report for Sep 30, 2024 (Q3 2024).
Over the last year, Chemed Corporation's Operating Income growth was 17.2%. The average annual Operating Income growth rates for Chemed Corporation have been (2.3%) over the past three years, 8.0% over the past five years.
Over the last year, Chemed Corporation's Operating Income growth was 17.2%, which is higher than industry growth of (0.0%). It indicates that Chemed Corporation's Operating Income growth is Good.